Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Von Willebrand Disease Clinical Trials
Von Willebrand Disease clinical trials are recruiting across 42 cities. Here are the cities with the most active studies:
Von Willebrand Disease Trial Phases
9 research organizations are sponsoring von willebrand disease trials.
About Von Willebrand Disease
Von Willebrand disease is the most common inherited bleeding disorder, caused by deficiency or dysfunction of von Willebrand factor, a protein needed for blood clotting. Most cases are mild with excessive bleeding during surgery or dental work. Treatment includes desmopressin and von Willebrand factor concentrates.
Clinical trials are advancing new treatments for von willebrand disease. Currently, 11 studies are recruiting a combined 1,185 participants across the United States. Research is being conducted by 9 organizations including VWD Connect Foundation, Hemab ApS, Vega Therapeutics, Inc and 6 others.
2026 Von Willebrand Disease Research Landscape
As of July 2026, the von willebrand disease clinical trial landscape includes 11 actively recruiting studies across 42 cities in the United States. These studies are collectively seeking 1,185 participants, with an average enrollment target of 108 per study.
The research spans multiple phases of development: 4 studies are in PHASE1, 3 studies are in PHASE3, 2 studies are in PHASE2. The presence of Phase 3 trials indicates that some von willebrand disease treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 9 different organizations, including VWD Connect Foundation, Hemab ApS, Vega Therapeutics, Inc, University of Washington, Hoffmann-La Roche, and 4 others.
Geographically, von willebrand disease trials are most concentrated in Atlanta, Georgia (5 trials); Los Angeles, California (4 trials); Indianapolis, Indiana (4 trials); Little Rock, Arkansas (3 trials); Miami, Florida (3 trials) and 7 other cities.
Featured Von Willebrand Disease Studies
Highlighted recruiting studies for von willebrand disease, selected by enrollment size and research scope.
The Severe Von Willebrand Disease (sVWD) Patient Registry
A web-based registry will be created by the sponsor, VWD Connect Foundation (VCF), to collect data on patients with severe Von Willebrand Disease (sVWD). Data will be self-reported by patients and/or collected by registry personnel, as appropriate. The purpose of the sVWD Patient Registry is to create a database of well-characterized (with respect to demographics, medical history, symptoms, labora...
A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
The purpose of this screening study is to accumulate information regarding bleeding events, quality of life, and the social and clinical impact of bleeds in participants with Von Willebrand Disease (VWD). Data from this study will be used to establish baseline bleeding and treatment rates in a population of participants with VWD and act as comparator data for future clinical study outcomes.(e.g. V...
Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
The VIVID study is structured in a master protocol format comprised of multiple parts that evaluate intravenous (IV) and subcutaneous (SC) VGA039 in healthy volunteers and subjects with von Willebrand Disease (VWD) and other bleeding disorders.
Frequently Asked Questions About Von Willebrand Disease Clinical Trials
Are there von willebrand disease clinical trials near me?
Yes, there are 11 von willebrand disease clinical trials currently recruiting across 42+ cities in the United States, including Atlanta, Georgia; Los Angeles, California; Indianapolis, Indiana. Browse the studies above to find one at a location convenient for you.
How do I join a von willebrand disease clinical trial?
To join a von willebrand disease clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are von willebrand disease clinical trials free?
Yes, participation in von willebrand disease clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of von willebrand disease treatments are being studied?
Current von willebrand disease clinical trials are testing a range of approaches across PHASE1 (4 studies), PHASE3 (3 studies), PHASE2 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 9 research organizations.
Is it safe to participate in von willebrand disease clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov